Murcko scaffold
Ring system with 9 rings and 52 atoms
42 chemicals on CompoundList share this ring system.
- Rings
- 9
- Scaffold atoms
- 52
- Chemicals
- 42
- With full pages
- 4
Scaffold SMILES
O=C(OC1CCCCO1)C12CCCCC1C1=CCC3C4CCC(OC5OCCC(OC6CCCCO6)C5OC5CCCCO5)CC4CCC3C1CC2
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 42 of 42 chemicals
Esculentoside N
CAS 141890-69-9C54H86O26
Esculentoside K
CAS 130364-34-0C54H86O25
beta-D-Glucopyranosyl (3beta)-3-((O-beta-D-glucopyranosyl-(1->3)-O-(beta-D-glucopyranosyl-(1->4))-beta-D-glucopyranosyl)oxy)olean-12-en-28-oate
CAS 144077-05-4C54H88O23
Araliasaponin V
C54H88O23
Tarasaponin VII
CAS 144118-18-3C52H84O21
Elatoside K
CAS 91204-06-7C53H84O23
![(3I(2))-28-(I(2)-D-Glucopyranosyloxy)-28-oxoolean-12-en-3-yl O-I+/--L-arabinopyranosyl-(1a2)-O-[I(2)-D-glucopyranosyl-(1a3)]-I(2)-D-glucopyranosiduronic acid chemical structure, C53H84O23, CAS 121521-91-3](/s/CAVHSWOJPOOWEG-HJFAYSLPSA-N.svg)
(3I(2))-28-(I(2)-D-Glucopyranosyloxy)-28-oxoolean-12-en-3-yl O-I+/--L-arabinopyranosyl-(1a2)-O-[I(2)-D-glucopyranosyl-(1a3)]-I(2)-D-glucopyranosiduronic acid
CAS 121521-91-3C53H84O23
Orb2893225
CAS 96158-11-1C53H84O23
Nudicaucin C
CAS 211815-98-4C53H86O21
Araliasaponin XIV
CAS 178603-39-9C54H88O23
Cephalaria saponin A
CAS 159650-08-5C53H86O22
Latifoloside C
CAS 194660-77-0C53H86O22
Kudinoside G
CAS 173792-64-8C53H86O22
Elatoside D
CAS 156856-40-5C54H86O24
Araloside V
CAS 340963-86-2C54H88O23
Araloside VII
CAS 340982-22-1C54H88O24
Araloside-V
C54H88O23
Congmunoside VII
C54H88O24
Matesaponin 2
CAS 164178-27-2C53H86O21
Congmunoside VII
C54H88O24
Calenduloside D
CAS 58231-98-4C54H88O23
![I(2)-D-Glucopyranosiduronic acid, (3I(2),16I(2))-28-(I(2)-D-glucopyranosyloxy)-16-hydroxy-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-glucopyranosyl-(1a2)]- chemical structure, C54H86O25, CAS 358732-33-9](/s/CQWDRHJHLPBCGO-GYEKFMRNSA-N.svg)
I(2)-D-Glucopyranosiduronic acid, (3I(2),16I(2))-28-(I(2)-D-glucopyranosyloxy)-16-hydroxy-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-glucopyranosyl-(1a2)]-
CAS 358732-33-9C54H86O25
![I(2)-D-Glucopyranosiduronic acid, (3I(2),21I(2))-28-(I(2)-D-glucopyranosyloxy)-21-hydroxy-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-glucopyranosyl-(1a2)]- chemical structure, C54H86O25, CAS 358732-35-1](/s/KBENXYXTLIQDHO-GYEKFMRNSA-N.svg)
I(2)-D-Glucopyranosiduronic acid, (3I(2),21I(2))-28-(I(2)-D-glucopyranosyloxy)-21-hydroxy-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-glucopyranosyl-(1a2)]-
CAS 358732-35-1C54H86O25
Araliasaponin VI
CAS 340982-21-0C54H88O24
- Elatoside C156856-39-2C53H84O23
- Molluscicidal agent-1111567-21-6C53H84O22
- (3I(2))-28-(I(2)-D-Glucopyranosyloxy)-28-oxoolean-12-en-3-yl O-I(2)-D-glucopyranosyl-(1a3)-O-[I(2)-D-xylopyranosyl-(1a2)]-I(2)-D-glucopyranosiduronic acidC53H84O23
- Cyaonoside A110081-91-9C54H86O23
- [(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aR,6aR,6aR,6bR,8aR,9R,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylateC54H88O24
- [(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aR,6aR,6aR,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylateC54H88O23
- Congmunoside VC54H88O23
- Congmunoside VIIC54H88O24
- CongmunosideVIIC54H88O24
- Congmunoside VC54H88O23
- Matesaponin 2C53H86O21
- I(2)-D-Glucopyranosiduronic acid, (3I(2))-28-(I(2)-D-glucopyranosyloxy)-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-xylopyranosyl-(1a2)]-, butyl ester329969-14-4C57H92O23
- I(2)-D-Glucopyranosiduronic acid, (3I(2))-28-(I(2)-D-glucopyranosyloxy)-28-oxoolean-12-en-3-yl O-I(2)-D-galactopyranosyl-(1a3)-O-[I(2)-D-xylopyranosyl-(1a2)]-, octyl ester256531-73-4C61H100O23
- Congmunoside VIIC54H88O24
- Congmunoside VC54H88O23
- [(2R,3R,4R,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aR,6bS,9R,10S,12aS,14bS)-10-[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylateC54H88O24
- [(2R,3R,4R,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aR,6bS,10S,12aS,14bS)-10-[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylateC54H88O23
- Congmunoside VIIC54H88O24